According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$4.43. In 2022 the company made an earnings per share (EPS) of -HK$5.99 an increase over its 2021 EPS that were of -HK$7.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$4.47 | -25.41% |
2022 | -HK$5.99 | -14.44% |
2021 | -HK$7.00 | -83.46% |
2020 | -HK$42.33 | -81.27% |
2019 | -HK$226.03 | -49% |
2018 | -HK$443.18 | -53.11% |
2017 | -HK$945.19 | -361.29% |
2016 | HK$361.74 | -146.98% |
2015 | -HK$770.00 | 279.31% |
2014 | -HK$203.00 | -120.57% |
2013 | HK$987.00 | -153.41% |
2012 | -HK$1,848 | -7.69% |
2011 | -HK$2,002 | 160% |
2010 | -HK$770.00 | 0% |
2009 | -HK$770.00 | |
2007 | -HK$3,157 | -2.38% |
2006 | -HK$3,234 | -39.13% |
2005 | -HK$5,313 | -16.87% |
2004 | -HK$6,391 | -22.43% |
2003 | -HK$8,239 | 5.94% |
2002 | -HK$7,777 | 60.32% |
2001 | -HK$4,851 | -12.5% |
2000 | -HK$5,544 | 2.86% |
1999 | -HK$5,390 | -13.58% |
1998 | -HK$6,237 | -2800% |
1997 | HK$231.00 | -101.76% |
1996 | -HK$13,110 |